Outcome of Botulinum Toxin‐A intraprostatic injection for benign prostatic hyperplasia induced lower urinary tract symptoms: A prospective multicenter study-Reference-Cited by-同舟云学术

Outcome of Botulinum Toxin‐A intraprostatic injection for benign prostatic hyperplasia induced lower urinary tract symptoms: A prospective multicenter study

Published:2019-06-12 Issue:11 Volume:79 Page:1221-1225
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Moussa Ayman S.¹^ORCID,Ragheb Ahmed M.¹,Abdelbary Ahmed M.¹,Ibrahim Rabie M.¹,El Adawy Mahmoud S.²,Aref Ahmad¹,Assem Ahmed³,Elfayoumy Hany³,Elzawy Faysal¹

Affiliation:

1. Urology Department, Faculty of MedicineBeni‐Suef UniversityBeni‐Suef Egypt

2. Urology Department, Faculty of MedicineFayoum UniversityFayoum Egypt

3. Urology DepartmentFaculty of Medicine, Cairo UniversityCairo Egypt

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23805

Reference24 articles.

1. BPH: epidemiology and comorbidities;McVary KT;Am J Manag Care,2006

2. UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA

3. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research;McConnell JD;Clin Pract Guidel Quick Ref Guide Clin,1994

4. DECREASED SENSORY RECEPTORS P2X 3 AND TRPV1 IN SUBUROTHELIAL NERVE FIBERS FOLLOWING INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN FOR HUMAN DETRUSOR OVERACTIVITY

5. Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury Patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulinum toxin therapy in urology: historical aspect;Urology reports (St. - Petersburg);2024-08-08

2. The use of Botulinum toxin in various urological conditions;Wiadomości Lekarskie;2024

3. Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?;Toxins;2022-07-18

4. Meta-analysis of botulinum toxin in the treatment of benign prostatic hyperplasia;Minerva Surgery;2022-01